Logo
Subscribe Now

All Posts by Date

Novartis Reports Results of LNP023 in P-II Study for Paroxysmal Nocturnal Hemoglobinuria

Novartis Reports Results of LNP023 in P-II Study for Paroxysmal Nocturnal Hemoglobinuria

World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan

World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan

AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-CKD Trial for Patients With and Without Type-2 Diabetes

AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-CKD Trial for Patients With and Without Type-2 Diabetes

Cadila Launches Cadalimab (biosimilar- adalimumab) in India

Cadila Launches Cadalimab (biosimilar- adalimumab) in India

Mylan and Biocon Launch Semglee (insulin glargine injection) as Vials and Pre-Filled Pen in the US

Mylan and Biocon Launch Semglee (insulin glargine injection) as Vials and Pre-Filled Pen in the US

Ionis to Acquire Remaining Stake in Akcea Therapeutics for $18.5/share

Ionis to Acquire Remaining Stake in Akcea Therapeutics for $18.5/share

Image

Stay Connected

We Have a Viewership of 1,00,000 + Views

Join the PharmaShot Family

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2021 PharmaShots - All Rights Reserved.